Clinical trial
Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin…
NCT00480181 · University of Manitoba, Other · Completed
Key facts
| NCT number | NCT00480181 |
|---|---|
| Title | Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis |
| Official title | A Comparative, Single Center, Randomized, Double-blinded, Parallel, Placebo-controlled Study to Evaluate the Efficacy of Nabilone (Cesamet) as Adjunctive Therapy to Gabapentin (Neurontin) in the Management of Neuropathic Pain (NPP) Symptoms in Subjects With Multiple Sclerosis (MS) |
| Lead sponsor | University of Manitoba, Other |
| Collaborators | Bausch Health Americas, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Neuropathic Pain, Multiple Sclerosis |
| Intervention type | Drug, Other |
| Interventions | nabilone, placebo |
| Enrollment | 50 |
| Start date | Jun 1, 2007 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | May 30, 2007 |
| Last update posted | Jul 27, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: